Submit your abstract

Abstract submission is now closed, the deadline was March 31, 2021.

Harold Gunson Fellowships

All Young Professionals who are 40 years or younger can apply for the Harold Gunson Fellowship.

Closing date for applications was March 31, 2021. If you submitted your application, you will be notified in a few weeks. 

Watch the tutorial on 'How to get your abstract accepted and how to present' it by Geoff Daniels

Abstract submission is closed

An international panel of experts will review and select abstracts for presentations. The first (presenting) author will receive a confirmation of acceptance, or a notice of rejection, by email in a few weeks.


1.1         Red Cell Immunohaematology - Serology

1.2         Red Cell Immunohaematology - Molecular

1.2         Rare Donors

2.1         Screening strategies for TTI

2.2         Hepatitis B (HBV)

2.3         Hepatitis C (HCV)

2.4         HIV

2.5         Bacteria

2.6         Parasites

2.7         Newly emerging Pathogens

2.8         Pathogen inactivation

3.1         Organisational Issues

3.2         Information Technology

3.3         Cost/effectiveness

3.4         Training and Education

3.5         Risk models, standards and regulation

3.6         Quality management

4.1         Platelet Immunology

4.2         Granulocyte immunology

4.3         Fetal-meternal immunology

4.4         TRALI

5.1         Stem cell and tissue banking

5.2         Collection, processing, storage and release

5.3         Clinical applications

5.4         Histocompatibility in stem cell transplantation

5.5         Histocompatibility in organ transplantation

6.1         Transufsion Reactions

6.2         Neonatal and Pediatric transfusion

6.3         Therapeutic apheresis

6.4         Evidence based transfusion medicine practice

6.5         Haemorrhage and massive transfusion

6.6         Adverse events, excluding TRALI

6.7         Haemovigilance and transfusion safety

6.8         Alternatives to blood transfusion




7.1         Blood supply management and utilization

7.2         blood doner recruitment

7.3         blood collection including apheresis

7.4         donors adverse events

8.1         PCR Testing

8.2         Anti-body testing

8.3         CCP

8.4         Clinical

9.1         Blood processing, storage and release

9.2         Blood components

9.3         Plasma products

9.4         Novel blood products



“At the ISBT Congress I learnt a lot from discussions, exchanging experiences and the good advice and suggestions from others, which I could implement at my institution’s blood bank.”

Merhan Fouda, Egypt
Become a member of ISBT join us now